Published in Health Serv Res on April 14, 2011
The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative welcome to medicare eye evaluation among persons without diagnosed diabetes mellitus. Arch Ophthalmol (2012) 1.49
Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol (2015) 1.06
Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol (2015) 1.03
Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol (2015) 0.91
Protective effects of fufang xueshuantong on diabetic retinopathy in rats. Evid Based Complement Alternat Med (2013) 0.85
Comparison of Manual Refraction Versus Autorefraction in 60 Diabetic Retinopathy Patients. Med Arch (2016) 0.79
Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities. J Diabetes Sci Technol (2015) 0.79
Attributes associated with eye care use in the United States: a meta-analysis. Ophthalmology (2013) 0.79
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up. BMC Ophthalmol (2016) 0.75
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol (1985) 17.20
Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA (1996) 14.23
Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol (2002) 14.17
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (2003) 8.76
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA (2000) 7.55
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. Value Health (2003) 6.02
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 5.91
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78
Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making (1985) 4.47
Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care (1998) 4.04
Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol (1991) 3.30
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol (1994) 3.24
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care (2003) 3.12
Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med (2004) 3.06
United States life tables, 2004. Natl Vital Stat Rep (2007) 3.03
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology (1995) 2.70
The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care (2006) 2.59
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Ophthalmology (2009) 2.57
Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med (1996) 2.46
Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol (1995) 2.46
Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care (1994) 2.30
Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology (1985) 2.26
Health care economic analyses and value-based medicine. Surv Ophthalmol (2003) 1.83
Utility values associated with blindness in an adult population. Br J Ophthalmol (2001) 1.79
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol (2004) 1.59
Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. Arch Ophthalmol (2006) 1.58
Comparison of nonmydriatic digital retinal imaging versus dilated ophthalmic examination for nondiabetic eye disease in persons with diabetes. Ophthalmology (2006) 1.53
Diabetic retinopathy. Diabetes Care (2003) 1.52
Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care (1991) 1.51
Detection of glaucoma-like optic discs in a diabetes teleretinal program. Optometry (2007) 1.47
Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group. Int Ophthalmol Clin (1987) 1.34
Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology (2003) 1.31
Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med (2004) 1.29
Incremental net benefit in randomized clinical trials. Stat Med (2001) 1.26
Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med (2001) 1.25
Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes (2010) 1.23
Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology: the Vine Hill study. Diabetes Care (2007) 1.22
Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res (2004) 1.20
The diagnosis of diabetic retinopathy. Ophthalmoscopy versus fundus photography. Ophthalmology (1993) 1.18
Screening for refractive errors with the Topcon PR2000 Pediatric Refractometer. Invest Ophthalmol Vis Sci (2000) 1.18
Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. Health Econ (2007) 1.17
Visual acuity change and mortality in older adults. Invest Ophthalmol Vis Sci (2005) 1.13
The sensitivity and specificity of direct ophthalmoscopic optic disc assessment in screening for glaucoma: a multivariate analysis. Graefes Arch Clin Exp Ophthalmol (2000) 1.13
Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology (2002) 1.12
Cost savings associated with detection and treatment of diabetic eye disease. Pharmacoeconomics (1995) 1.09
Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program. Retina (2003) 1.07
A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health (2005) 1.05
Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology (2009) 1.04
Methods for detecting age-related maculopathy: a comparison between photographic and clinical assessment. Clin Experiment Ophthalmol (2000) 1.00
Cost-effectiveness of vitamin therapy for age-related macular degeneration. Ophthalmology (2007) 0.98
Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom. Arch Ophthalmol (2005) 0.94
Defining myopia using refractive error and uncorrected logMAR visual acuity >0.3 from 1334 Singapore school children ages 7-9 years. Br J Ophthalmol (2006) 0.90
Screening for myopia and refractive errors using LogMAR visual acuity by optometrists and a simplified visual acuity chart by nurses. Optom Vis Sci (2004) 0.89
Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches. Ophthalmic Epidemiol (2007) 0.88
UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes. J Diabetes Complications (2002) 0.81
How often should patients with diabetes be screened for retinopathy? JAMA (2000) 0.80
Detection of glaucoma-like optic discs in a diabetes teleretinal program. Optometry (2008) 0.79
Systematic screening for diabetic retinopathy with a digital fundus camera following pupillary dilatation in a university diabetes department. Diabet Med (2007) 0.79
Relative risk of mortality associated with diabetes as a function of birth weight. Diabetes Care (2005) 0.78
How often should patients with diabetes be screened for retinopathy? JAMA (2000) 0.76
How often should patients with diabetes be screened for retinopathy? JAMA (2000) 0.76
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med (2013) 7.17
Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75
The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol (2004) 6.53
The evolving diabetes burden in the United States. Ann Intern Med (2004) 6.36
Diabetic retinopathy. N Engl J Med (2012) 5.79
Is glycemic control improving in U.S. adults? Diabetes Care (2007) 5.30
Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care (2006) 5.25
Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract (2010) 5.16
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA (2010) 4.41
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Retinopathy in diabetes. Diabetes Care (2004) 4.25
The impact of hearing loss on quality of life in older adults. Gerontologist (2003) 3.87
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med (2011) 3.80
A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol (2005) 3.74
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
Revised formulas for summarizing retinal vessel diameters. Curr Eye Res (2003) 3.47
Prevalence of olfactory impairment in older adults. JAMA (2002) 3.46
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17
The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Arch Otolaryngol Head Neck Surg (2003) 3.17
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes (2006) 3.00
Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol (2009) 2.97
Diabetic retinopathy. Diabetes Care (2004) 2.97
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet (2003) 2.92
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol (2006) 2.89
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet (2008) 2.89
Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol (2011) 2.89
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83
Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci (2006) 2.79
Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA (2002) 2.78
Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics (2007) 2.75
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
Long-term use of aspirin and age-related macular degeneration. JAMA (2012) 2.72
Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care (2002) 2.70
The Los Angeles Latino Eye Study: design, methods, and baseline data. Ophthalmology (2004) 2.68
ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst (2002) 2.64
Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med (2006) 2.60
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Ophthalmology (2009) 2.57
Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol (2013) 2.52
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet (2008) 2.49
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology (2003) 2.36
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology (2012) 2.31
Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology (2004) 2.26
Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol (2009) 2.18
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med (2004) 2.18
A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis (2010) 2.15
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol (2008) 2.14
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ann Intern Med (2009) 2.14
Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology (2004) 2.12
Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ (2004) 2.10
Low birthweight is associated with narrower arterioles in adults. Hypertension (2008) 2.08
Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care (2009) 2.08
Age-related macular degeneration and risk for stroke. Ann Intern Med (2006) 2.07
Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology (2003) 2.04
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis (2010) 1.96
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol (2008) 1.93
Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care (2006) 1.93
The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.92
Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology (2006) 1.91
Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke (2010) 1.91
Quantitative and qualitative retinal microvascular characteristics and blood pressure. J Hypertens (2011) 1.89
Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis. J Hypertens (2009) 1.89
Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med (2004) 1.89
Blindness, visual impairment and the problem of uncorrected refractive error in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.86
Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol (2008) 1.85
Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus. Arch Ophthalmol (2011) 1.85
Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension (2007) 1.83
EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet (2009) 1.82
Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology (2003) 1.81
Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA (2002) 1.80
Genome-wide linkage study of retinal vessel diameters in the Beaver Dam Eye Study. Hypertension (2006) 1.80
Identification of novel genetic loci for intraocular pressure: a genomewide scan of the Beaver Dam Eye Study. Arch Ophthalmol (2007) 1.79
Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke (2005) 1.78
Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke (2002) 1.77
Addressing the burden of diabetes in the 21st century: better care and primary prevention. J Am Soc Nephrol (2003) 1.77
The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study. Arch Otolaryngol Head Neck Surg (2011) 1.76
Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology (2009) 1.76
Racial/ethnic differences in the healthcare experience (coverage, utilization, and satisfaction) of US adults with diabetes. Ethn Dis (2003) 1.75
Frailty, morbidity and survival. Arch Gerontol Geriatr (2005) 1.75
Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology (2004) 1.75
Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension (2006) 1.74